LFWD Lifeward
- 3.130
- -0.050-1.57%
- 3.130
- 0.0000.00%
Lifeward News
ReWalk Robotics Renames as Lifeward
ReWalk Robotics Ltd. Finalizes Corporate Name Change To Lifeward Ltd.
Press Release: Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research
Lifeward's First Annual Step Challenge Donates €5,000 to German Association for People Living With Spinal Cord Injury
ReWalk Robotics Approves Directors and Company Renaming at Annual Meeting
Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference
ReWalk Robotics Second Quarter 2024 Earnings: EPS Beats Expectations
Lake Street Maintains ReWalk Robotics(LFWD.US) With Buy Rating, Maintains Target Price $8.5
Rewalk Robotics Analyst Ratings
H.C. Wainwright Maintains ReWalk Robotics(LFWD.US) With Buy Rating, Maintains Target Price $13
Analysts Offer Insights on Healthcare Companies: Hoth Therapeutics (HOTH), Rewalk Robotics (LFWD) and Rani Therapeutics Holdings (RANI)
Express News | Rewalk Robotics Ltd : H.c. Wainwright Raises Target Price to $13 From $9
ReWalk Robotics Ltd. (LFWD) Q2 2024 Earnings Call Transcript Summary
ReWalk Robotics Ltd. (LFWD) Q2 2024 Earnings Call Transcript
Express News | ReWalk Robotics Shares Are Trading Higher. The Company Reported Q2 Financial Results
Lake Street Initiates ReWalk Robotics(LFWD.US) With Buy Rating, Announces Target Price $8.5
Lake Street Remains a Buy on Rewalk Robotics (LFWD)
ReWalK Non-GAAP EPS of -$0.42, Revenue of $6.7M Beats by $0.05M; Reaffirms FY24 Outlook
ReWalk Robotics 2Q Loss/Shr 50c >LFWD
ReWalk Robotics 2Q Rev $6.71M >LFWD
Analysis
Price Target
No Data
No Data